Global Emerging Market Equities, Propitious Research

Wium Malan, CFA

Global Emerging Market Equities

Independent, Fundamental Quantitative Research

Propitious Research

Fully independent, fundamental and quantitative equity research, focused on companies in the Telecommunication, Media, Technology, Internet and Healthcare sectors in the Global Emerging Markets. Idea generation focused on Quality stocks, trading below their intrinsic Value, with sound Corporate Governance.

Quantitative Analysis

<ul>
<li>An overview (and output) of our machine learning-driven GEM screening model, which seeks to find the best medium-term long ideas within the top 100 stocks in the MSCI GEM Index.</li>
<li>The model is based on 1) a quantitative multifactor screening model, enhanced by two AI Technology-based approaches; 2) a Deep Neural Network model, and 3) a Recurrent Neural Network model.</li>
<li>Developed over roughly 4 years and implemented in its current state for over 3 years, the model has a solid real-world alpha-generating performance track record, discussed in detail below.</li>
</ul>


An overview (and output) of our machine learning-driven GEM screening model, which seeks to find the best medium-term long ideas within the top 100 stocks in the MSCI GEM Index.
The model is based on 1) a quantitative multifactor screening model, enhanced by two AI Technology-based approaches; 2) a Deep Neural Network model, and 3) a Recurrent Neural Network model.
Developed over roughly 4 years and implemented in its current state for over 3 years, the model has a solid real-world alpha-generating performance track record, discussed in detail below.


Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Bottom-Up

<ul>
<li>China announced game approval for the Feb batch. The number of games approved remained at a higher level than 2023.</li>
<li>The pace of China game approval appears to have accelerated to the same level as pre-tightening.</li>
<li>However, neither Tencent and Netease got any approval in March.</li>
</ul>


China announced game approval for the Feb batch. The number of games approved remained at a higher level than 2023.
The pace of China game approval appears to have accelerated to the same level as pre-tightening.
However, neither Tencent and Netease got any approval in March.


Tencent/Netease: Both Zeroed in March Game Approval

Blue Lotus Non US Internet research, Blue Lotus Research Institute

Ying Pan

Blue Lotus Non US Internet research

China growth and global non-US Internet equities

Blue Lotus Research Institute

Blue Lotus Research is a Hong Kong Type 4 Licensed investment advisory firm focusing on Chinese growth equities and global non-US Internet equities

Thematic (Sector/Industry)

<ul>
<li>NTES：Source stated that NetEase is developing a 6V6 Marvel IP third-person shooter game.（+）</li>
<li>BABA US : Analyst Call hosted by Alibaba regarding the withdrawal of the Cainiao IPO？（/）</li>
<li>BABA US : Alibaba to launch LLM for advertising. (+)</li>
</ul>


NTES：Source stated that NetEase is developing a 6V6 Marvel IP third-person shooter game.（+）
BABA US : Analyst Call hosted by Alibaba regarding the withdrawal of the Cainiao IPO？（/）
BABA US : Alibaba to launch LLM for advertising. (+)


[Blue Lotus Daily - TMT Update]:NTES/BABA

<ul>
<li>We analyzed the latest HK SFC report for aggregate short position as of Mar 15th.</li>
<li>Top short increases and decreases were tabulated for one week and four week period. </li>
<li>We highlight short changes in Techtronic Ind, Zijin Mining, Innovent Bio, Kuaishou, Pacific Basin, Citic Sec, Link Reit, CKI.</li>
</ul>


We analyzed the latest HK SFC report for aggregate short position as of Mar 15th.
Top short increases and decreases were tabulated for one week and four week period. 
We highlight short changes in Techtronic Ind, Zijin Mining, Innovent Bio, Kuaishou, Pacific Basin, Citic Sec, Link Reit, CKI.


HK Short Interest Weekly: Techtronic Ind, Zijin Mining, Innovent Bio, Kuaishou, Pacific Basin

<ul>
<li>SHEIN/PDD: France to restrict sales of fast - fashion (-/-)</li>
<li>NTES: After The Release of The New Expansion Pack For &lt;Beyond the World&gt;, It Climbed to the 3rd Position on iOS Games Grossing Chart in China (+)</li>
<li>6618 HK：JD Health's revenue in 2H23 exceeded expectations, while profits fell short, and revenue and profit guidance for 2024 both worse than consensus（-）</li>
</ul>


SHEIN/PDD: France to restrict sales of fast - fashion (-/-)
NTES: After The Release of The New Expansion Pack For &lt;Beyond the World&gt;, It Climbed to the 3rd Position on iOS Games Grossing Chart in China (+)
6618 HK：JD Health's revenue in 2H23 exceeded expectations, while profits fell short, and revenue and profit guidance for 2024 both worse than consensus（-）


[Blue Lotus Daily - TMT Update]:SHEIN/PDD/NTES/6618 HK

China

NetEase, Inc. is an Internet technology company that develops applications, services and other Internet technologies in China. The Company's core businesses consist of email service, web portal and online entertainment, including online gaming services. NetEase also offers online advertising, search, mobile applications and e-commerce.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

NetEase Inc (NTES US)

Screening for GEMs: April 2024

This insight provides an overview of our, machine learning-driven, proprietary GEM screening model, based on a Multifactor model, a Deep Neural...

Wium Malan, CFA

Tencent/Netease: Both Zeroed in March Game Approval

China's game approval process shows higher levels than in 2023, with an accelerated pace resembling pre-tightening, but major companies like...

Ke Yan, CFA, FRM

[Blue Lotus Daily - TMT Update]:NTES/BABA

Source stated that NetEase is developing a 6V6 Marvel IP third-person shooter game, Alibaba cancels Cainiao IPO, lAlibaba to launch LLM for...

Blue Lotus Research Institute

HK Short Interest Weekly: Techtronic Ind, Zijin Mining, Innovent Bio, Kuaishou, Pacific Basin

We analyzed the latest HK SFC report for aggregate short position as of Mar 15th and highlight short interest changes in Techtronic Ind, Zijin...

Ke Yan, CFA, FRM

[Blue Lotus Daily - TMT Update]:SHEIN/PDD/NTES/6618 HK

France to restrict sales of fast-fashion; JD Health's revenue exceeds expectations but profits fall short with worse guidance for 2024. NTES...

Blue Lotus Research Institute

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Screening for GEMs: April 2024

This insight provides an overview of our, machine learning-driven, proprietary GEM screening model, based on a Multifactor model, a Deep Neural...

Wium Malan, CFA

Tencent/Netease: Both Zeroed in March Game Approval

​China's game approval process shows higher levels than in 2023, with an accelerated pace resembling pre-tightening, but major companies like...

Ke Yan, CFA, FRM

[Blue Lotus Daily - TMT Update]:NTES/BABA

Source stated that NetEase is developing a 6V6 Marvel IP third-person shooter game, Alibaba cancels Cainiao IPO, lAlibaba to launch LLM for...

Blue Lotus Research Institute

HK Short Interest Weekly: Techtronic Ind, Zijin Mining, Innovent Bio, Kuaishou, Pacific Basin

We analyzed the latest HK SFC report for aggregate short position as of Mar 15th and highlight short interest changes in Techtronic Ind, Zijin...

Ke Yan, CFA, FRM

[Blue Lotus Daily - TMT Update]:SHEIN/PDD/NTES/6618 HK

​France to restrict sales of fast-fashion; JD Health's revenue exceeds expectations but profits fall short with worse guidance for 2024. NTES...

Blue Lotus Research Institute

China's game approval process shows higher levels than in 2023, with an accelerated pace resembling pre-tightening, but major companies like...

France to restrict sales of fast-fashion; JD Health's revenue exceeds expectations but profits fall short with worse guidance for 2024. NTES...